Frontlight ResearchEarly access
Lung cancer trials in Ukraine
1 of 11 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleKEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- Where
- Cherkasy, Ivano-Frankivsk, Rivne, Uzhhorod
- Age
- 18 years and over
- People
- 1,065 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04165798